The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Novartis Ireland Limited naming Simon Harris .

Filed returns
7
match these filters
Matching filed returns per period 0 1 2 3 5 May–Aug 2016: 1 filed returns May–Aug 2017: 1 filed returns May–Aug 2025: 3 filed returns Sep–Dec 2025: 2 filed returns
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Sep–Dec 2025 Novartis Ireland Limited Health Forwarding letter to Dept of Health about access to innovative treatment for Irish patients (Public policy or programme) 6 On lobbying.ie
Sep–Dec 2025 Novartis Ireland Limited Health Advocate for Life Science Strategy (Public policy or programme) 7 On lobbying.ie
May–Aug 2025 Novartis Ireland Limited Health Letter to Tanaiste about access to innovative treatment for Irish patients (Public policy or programme) 5 On lobbying.ie
May–Aug 2025 Novartis Ireland Limited Health Rare diseases conference, as an official event of the Irish EU Presidency (Public policy or programme) 6 On lobbying.ie
May–Aug 2025 Novartis Ireland Limited Health IPHA Industry meeting - engagement on trade and tariff issues (Legislation) 1 On lobbying.ie
May–Aug 2017 Novartis Ireland Limited Health Highlight delay in reimbursing Entresto (Heart Failure medine), the first new innovation in heart failure in a decade considered cost effective in July 2016 (Matters involving public funds) 23 On lobbying.ie
May–Aug 2016 Novartis Ireland Limited Health Ensure that the 2016 Framework Agreement on the Pricing and Supply of Medicines is resolved by aggreement, not legislation (Public policy or programme) 5 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 7 100.0%